BioCentury | Jul 7, 2017
Finance

Generalists needed

...A) 5/24/17 $8.5 NA $54.3 NA Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) 5/24/17 $49.7 $291.6 $307.4 5% InMed Pharmaceuticals Inc....
BioCentury | Jun 2, 2017
Financial News

InMed closes C$5.8M follow-on

...Cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$5.8 million ($4.3 million) through the sale of 12.8...
...include a 1.7 million unit overallotment sold on May 31. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alex Himes InMed Pharmaceuticals Inc....
BioCentury | Apr 28, 2017
Financial News

InMed proposes follow-on

...a follow-on underwritten by Canaccord Genuity and Roth Capital Partners. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alicia Parker InMed Pharmaceuticals Inc....
BioCentury | Jan 20, 2017
Financial News

InMed completes private placement

...On Jan. 18, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$1.5 million ($1.1 million) through the...
...of 8.3 million shares at C$0.18 in a private placement. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alicia Parker InMed Pharmaceuticals Inc....
BioCentury | Mar 5, 2015
Company News

Management tracks

...CEO from CBO. He succeeds Christopher Prior, who resigned in October 2014. Cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc....
BioCentury | Mar 2, 2015
Financial News

InMed Pharmaceuticals Inc completes private placement of units

InMed Pharmaceuticals Inc . (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Business: Ophthalmic, Dermatology Date completed: 2015-02-25 Type: Private placement of units Raised: C$1.1 million ($834,645) Units: 10.5 million Price: C$0.10 (unit) Shares after offering: 51.4 million Note: Each...
Items per page:
1 - 6 of 6
BioCentury | Jul 7, 2017
Finance

Generalists needed

...A) 5/24/17 $8.5 NA $54.3 NA Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) 5/24/17 $49.7 $291.6 $307.4 5% InMed Pharmaceuticals Inc....
BioCentury | Jun 2, 2017
Financial News

InMed closes C$5.8M follow-on

...Cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$5.8 million ($4.3 million) through the sale of 12.8...
...include a 1.7 million unit overallotment sold on May 31. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alex Himes InMed Pharmaceuticals Inc....
BioCentury | Apr 28, 2017
Financial News

InMed proposes follow-on

...a follow-on underwritten by Canaccord Genuity and Roth Capital Partners. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alicia Parker InMed Pharmaceuticals Inc....
BioCentury | Jan 20, 2017
Financial News

InMed completes private placement

...On Jan. 18, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$1.5 million ($1.1 million) through the...
...of 8.3 million shares at C$0.18 in a private placement. InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Alicia Parker InMed Pharmaceuticals Inc....
BioCentury | Mar 5, 2015
Company News

Management tracks

...CEO from CBO. He succeeds Christopher Prior, who resigned in October 2014. Cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc....
BioCentury | Mar 2, 2015
Financial News

InMed Pharmaceuticals Inc completes private placement of units

InMed Pharmaceuticals Inc . (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Business: Ophthalmic, Dermatology Date completed: 2015-02-25 Type: Private placement of units Raised: C$1.1 million ($834,645) Units: 10.5 million Price: C$0.10 (unit) Shares after offering: 51.4 million Note: Each...
Items per page:
1 - 6 of 6